From: Effect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcoma
T0 | T1 | T2 | P value | ||
---|---|---|---|---|---|
N = 27 (%) | N = 20 (%) | N = 9 (%) | T 0 vs T 1 | T 0 vs T 2 | |
Sex | 0.25 | 0.56 | |||
M | 24 (88.9) | 20 (100.0) | 9 (100.0) | ||
F | 3 (11.1) | 0(0.0) | 0 (0.0) | ||
Age | 0.72 | 1.00 | |||
≤ 65 years | 6 (22.2) | 5 (25.0) | 2 (22.2) | ||
> 65 years | 21 (77.8) | 15 (75.0) | 7 (77.8) | ||
HHV8 DNA in PBMCs | |||||
Positive | 13 (48.1) | 4 (20.0) | 2 (22.2) | 0.07 | 0.25 |
Negative | 14 (51.9) | 16 (80.0) | 7 (77.8) | ||
KS lesion persistence | |||||
Yes | 27 (100.0) | 8 (40.0) | 4 (44.4) | 0.0001 | 0.0003 |
No | 0 (0.0) | 12 (60.0) | 5 (55.6) | ||
HHV8 DNA in classic KS | |||||
Positive | 27 (100.0) | ||||
Negative | 0 (0.0) |